Breo Ellipta 100 mcg

BREO ELLIPTA 100 MCG is an inhalation powder containing fluticasone furoate, used for managing respiratory conditions. This medication helps reduce inflammation in the lungs, aiding in better breathing. Ideal for those seeking relief from chronic respiratory issues.

BREO ELLIPTA 100 MCG is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. It works by reducing inflammation in the lungs, which can help improve breathing and reduce symptoms such as wheezing and shortness of breath. This medication is often prescribed for long-term management rather than for immediate relief of acute symptoms.

Common effects of BREO ELLIPTA 100 MCG may include throat irritation, hoarseness, and oral thrush. Some users might experience headaches or nasal congestion. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

BREO ELLIPTA 100 MCG should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of thrush. Avoid sudden discontinuation without medical advice, as this can worsen symptoms. Keep the medication out of reach of children and store it properly to maintain its effectiveness.

BREO ELLIPTA 100 MCG may interact with other medications, including certain antifungal and antiviral drugs. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other respiratory medications should be used with caution while on this treatment.